Novo Nordisk’s Weight-Loss Drug Sales Plummet, Putting Denmark’s Export Boom at Risk
Novo Nordisk's weight-loss drug sales are experiencing a significant downturn, raising concerns about a potential export slowdown for Denmark. As ...
Read moreNovo Nordisk's weight-loss drug sales are experiencing a significant downturn, raising concerns about a potential export slowdown for Denmark. As ...
Read moreIn Ireland, a key player in the global pharmaceutical arena, worries are rising over the lingering effects of Trump-era tariffs. ...
Read moreA revolutionary Alzheimer’s drug is on its way to Luxembourg pharmacies, bringing a wave of hope for patients and their ...
Read moreBulgaria's struggling drug market is putting patient health at serious risk, with shortages of vital medications becoming alarmingly frequent. Industry ...
Read moreIn a recent episode of The Guardian's podcast, "Streams of Medicines," experts dive into Switzerland's cutting-edge strategies to tackle pharmaceutical ...
Read moreSlovenia's Krka pharmaceutical company is set to boost its dividend by 10% in 2024, showcasing impressive financial strength and a ...
Read moreAlvotech has taken a bold step forward by acquiring Xbrane's R&D operations in Sweden, boosting its biosimilar development expertise. This ...
Read moreAuthorities in Louisville have just intercepted a massive shipment of ketamine valued at $775,000, traced back to Belgium and France. ...
Read moreIn a remarkable turnaround, Denmark has seen a striking drop in drug reimbursement costs, showcasing the government's commitment to smarter ...
Read more© 2024 EUROP.INFO - Copyright for syndicated content belongs to the linked Source.
© 2024 EUROP.INFO - Copyright for syndicated content belongs to the linked Source.